Real-time enrollment status for this diabetic peripheral neuropathic pain clinical trial
Current Status
Recruiting
Checked: August 30, 2026 at 2:36 PM UTC
| NCT Number | NCT06361108 |
| Recruiting Status | Recruiting |
| Condition | Diabetic Peripheral Neuropathic Pain |
| Phase | PHASE1 |
| Target Enrollment | 24 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Zhejiang Hanmai Pharmaceutical Technology Co., Ltd. |
| Last Updated on CT.gov | August 13, 2025 (Aug 13, 2025) |
As of August 30, 2026: Clinical trial NCT06361108 is currently recruiting participants. This phase1 study for diabetic peripheral neuropathic pain is actively seeking new participants at 1 location across the United States. The study is sponsored by Zhejiang Hanmai Pharmaceutical Technology Co., Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06361108 is actively recruiting participants as of August 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06361108 was last updated Aug 13, 2025 (August 13, 2025). HelloStudys verifies this status automatically.